Informing antimicrobial stewardship with explainable AI

Massimo Cavallaro, Ed Moran, Benjamin Collyer, Noel D. McCarthy, Christopher Green, Matt J. Keeling

Research output: Contribution to journalArticlepeer-review

Abstract

The accuracy and flexibility of artificial intelligence (AI) systems often comes at the cost of a decreased ability to offer an intuitive explanation of their predictions. This hinders trust and discourage adoption of AI in healthcare, exacerbated by concerns over liabilities and risks to patients’ health in case of misdiagnosis. Providing an explanation for a model’s prediction is possible due to recent advances in the field of interpretable machine learning. We considered a data set of hospital admissions linked to records of antibiotic prescriptions and susceptibilities of bacterial isolates. An appropriately trained gradient boosted decision tree algorithm, supplemented by a Shapley explanation model, predicts the likely antimicrobial drug resistance, with the odds of resistance informed by characteristics of the patient, admission data, and historical drug treatments and culture test results. Applying this AI-based system, we found that it substantially reduces the risk of mismatched treatment compared with the observed prescriptions. The Shapley values provide an intuitive association between observations/data and outcomes; the associations identified are broadly consistent with expectations based on prior knowledge from health specialists. The results, and the ability to attribute confidence and explanations, support the wider adoption of AI in healthcare.
Original languageEnglish
Article numbere0000162
JournalPLOS digital health
Volume2
Issue number1
DOIs
Publication statusPublished - 5 Jan 2023

Bibliographical note

Funding: This work was supported by Health Data Research UK, which is funded by the UK Medical Research Council, EPSRC, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and the Wellcome Trust supported MC, MJK, and NDM. MJK and NDM are affiliated to the National Institute for Health Research Health Protection Research Units (NIHR HPRUs) in Gastrointestinal Infections and in Genomics and Enabling Data. MJK is funded by UK Research and Innovation through the JUNIPER modelling consortium (MR/V038613/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Fingerprint

Dive into the research topics of 'Informing antimicrobial stewardship with explainable AI'. Together they form a unique fingerprint.

Cite this